drugset / Trial / NCT02935309
Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma
NaSingle-groupOpen-labelTreatment
Summary
This research study is designed to see if Capecitabine and Lenvatinib in combination with external radiation therapy are effective in treating locally advanced rectal adenocarcinoma in patients who have not yet had surgery, and what the best dosage is.
Timeline
- Start
- 2016-10-14
- Primary completion
- 2019-10-11
- Completion
- 2020-05-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 850 mg/m2 | — |
| Subject | Lenvatinib | Small molecule | 10 mg | Oral |
| Subject | Lenvatinib | Small molecule | 14 mg | Oral |
| Subject | Lenvatinib | Small molecule | 20 mg | Oral |
| Subject | Lenvatinib | Small molecule | 24 mg | Oral |